Viewing nowNew Valsartan Tablet 80 mg (Valsartan)
Valsartan 80mg
Tablet · Prescription medication
Anguk Newpharm Co., Ltd.

MFDS item code 201800822 · Approved 2018.02.14 · Insurance code 053600610
Treatment of hypertension, treatment of heart failure, reduction of the risk of death after myocardial infarction
This medication is used to reduce the risk of mortality that may occur after essential hypertension, heart failure, and myocardial infarction. It is particularly effective in heart failure patients who cannot use ACE inhibitors. Additionally, it helps reduce the risk of mortality in stable myocardial infarction patients with left ventricular dysfunction or left ventricular systolic dysfunction. Through these efficacies, it contributes to improving cardiovascular health.
1. Essential hypertension Take with water during or between meals. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). 1) Adults: Regardless of sex or race, oral administration of 80 mg of valsartan once daily is recommended. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg daily or a diuretic may be administered concomitantly. If further blood pressure reduction is needed, the dose may be increased up to a maximum of 320 mg daily. 2) Older adults (75 years or older): Initiate treatment with 40 mg of this medicine once daily. 3) Patients with renal impairment: (1) Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is necessary. (2) Creatinine clearance 10 ∼ 20 mL/min: Initiate treatment with 40 mg of this medicine once daily. (3) Creatinine clearance less than 10 mL/min and patients on dialysis: Do not administer this medicine. 4) Patients with volume depletion: For patients with volume depletion (e.g., patients taking high doses of diuretics whose dose cannot be reduced), initiate treatment with 40 mg of this medicine once daily. 5) Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, initiate treatment with 40 mg of this medicine once daily; the dose should not exceed 80 mg daily. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure Adults: The recommended initial dose is 40 mg of this medicine orally twice daily; the dose may be increased to 80 mg or 160 mg per dose. When administered concomitantly with a diuretic, consider reducing the diuretic dose. The maximum daily dose is 320 mg, administered in divided doses. Triple combination therapy with this medicine, an ACE inhibitor, and a beta-blocker is not recommended. 3. Reduction of risk of death after myocardial infarction Adults: Treatment may be initiated within 12 hours after the onset of myocardial infarction. The recommended initial dose is 20 mg of this medicine twice daily, followed by dose increases over several weeks to 40 mg, 80 mg, and 160 mg per dose twice daily, taking the patient's tolerability into account. Consider dose reduction if symptoms of hypotension or renal failure occur. This medicine may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytic agents, acetylsalicylic acid, beta-blockers, and statins). However, concomitant use with an ACE inhibitor is not recommended. 4. Patients with renal impairment: No dose adjustment is necessary when creatinine clearance is 10 mL/min or higher. However, this medicine should not be administered to patients with creatinine clearance less than 10 mL/min or patients on dialysis, as there is no experience with its use in these patients. 5. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of this medicine should preferably not exceed 80 mg. If administering 80 mg or more daily, consider whether the benefits of treatment outweigh the risks when increasing the dose. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis.
Children and adolescents younger than 18 years: Safety and efficacy have not been established.
This medication can cause serious harm to the fetus if taken during pregnancy, especially during the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It is safer for women who may become pregnant or are breastfeeding not to take this medication. This medication is not administered to patients with severe liver dysfunction or specific liver diseases or severe renal impairment. People who have an allergic reaction to this medication should also refrain from using it. Caution is particularly necessary for elderly patients or patients with high potassium levels or slightly impaired liver function. Blood pressure may drop too low, or dizziness may occur, so starting at a low dose is advised, and conditions must be carefully monitored. Patients with heart failure or post-myocardial infarction should also carefully monitor for changes in renal function. The blood potassium levels may rise dangerously when taken with other antihypertensive medications, diuretics, or potassium supplements, so caution is advised. Additionally, using this medication with certain anti-inflammatory pain relievers may reduce blood pressure control effects, so caution is required. Possible side effects include headache, dizziness, fatigue, cough, indigestion, and, rarely, serious adverse reactions such as angioedema, renal impairment, or hepatitis. If any abnormal symptoms occur, consult a healthcare professional immediately. This medication is not recommended for use in children or adolescents as safety and efficacy have not been established. In case of overdose, blood pressure may drop sharply, and loss of consciousness may present a risk, so immediate emergency treatment is required. Store this medication out of reach of children and do not transfer it to another container.
headache
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a well-sealed container to prevent air and moisture entry. It is also important to store it in a cool place below 30 degrees Celsius to maintain its effectiveness.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowValsartan 80mg
Tablet · Prescription medication
Anguk Newpharm Co., Ltd.

Valsartan 80mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 160mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 40mg
Tablet · Prescription medication
Samsung Novartis Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan 320mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.